Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs TeleClinic

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and TeleClinic head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 97 · Grade C

TeleClinic

Visit TeleClinic Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 75 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make TeleClinic a bad call — it's best for readers comparing first-month offers who will obtain a medication-specific renewal price and the written price-lock conditions before enrollment. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
36
Supply Reliability
95
87
Transparency
90
94
Access Breadth
93
84
Clinical Oversight
92
80
Track Record
88
79
CoreAge RxBrief Score 94 · 75TeleClinic

Price, coverage & the tracker

CoreAge RxTeleClinic
Brief Score94/100 (A)75/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm ongoing renewal price

Introductory $79 first month or $179 for first three months; generic price-lock terms differ.

Full price details

Compounded semaglutide offered; current renewal quote unknown; earlier listing: From $199/mo (compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm ongoing renewal price

Introductory $149 first month or $399 for first three months; generic price-lock terms differ.

Full price details

Compounded tirzepatide offered; current renewal quote unknown; earlier listing: From $299/mo (compounded)

CoverageUS only; restrictions by state, confirmed at intake47 states advertised; medication-specific state eligibility requires confirmation
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

TeleClinic: Current introductory offers differ from the generic price-lock table. Confirm the medication-specific renewal quote; earlier $199/$299 observations are historical.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.